Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2009; 15(22): 2731-2738
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2731
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2731
Table 3 Effect of celecoxib on COX-2 expression and other parameters
| Celecoxib group n (%) | Placebo group n (%) | |||||
| Reduction | Same | Worse | Reduction | Same | Worse | |
| COX-2 expression | 22 (73) | 4 (13) | 4 (13) | 15 (48) | 3 (10) | 13 (43) |
| Cell proliferation | 23 (77) | 2 (7) | 5 (17) | 11 (37) | 3 (10) | 16 (53) |
| Cell apoptosis | 8 (53) | 4 (27) | 3 (20) | 4 (27) | 5 (17) | 6 (40) |
| Angiogenesis | 22 (73) | 4 (13) | 4 (13) | 12 (39) | 10 (32) | 9 (29) |
| PPARγ expression | 15 (50) | 5 (17) | 10 (33) | 9 (29) | 5 (16) | 17 (55) |
-
Citation: Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J. Anti-
Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World J Gastroenterol 2009; 15(22): 2731-2738 - URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2731.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2731